Paul Schimmel - 27 May 2026 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 May 2026, 16:12:51 UTC
Prior SEC filing
13 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nancy E. Denyes, as Attorney-in-Fact

Key filing fact

Paul Schimmel filed Form 4 for aTYR PHARMA INC (ATYR) on 28 May 2026.

Key facts

  • This page summarizes Paul Schimmel's Form 4 filing for aTYR PHARMA INC (ATYR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 28 May 2026, 16:12.

Change

  • Previous filing in this sequence was filed on 13 May 2026.
  • Current net transaction value: +$49,630.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001236447 Primary reporting owner

SCHIMMEL PAUL

Relationship
Director
Address
C/O ATYR PHARMA, INC., 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Signature date
28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATYR transaction

Common Stock

Purchase

Transaction value
$49,630
Shares
+100,000
Change %
+15%
Price
$0.4963
Shares after
779,143
Date
27 May 2026
Ownership
See Footnote
Footnotes
F1, F2
ATYR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,890
Date
27 May 2026
Ownership
Direct
ATYR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,413,023
Date
27 May 2026
Ownership
See Footnote
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.4907 to $0.50 per share. The Reporting Person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.

Footnote F2

These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.

Footnote F3

These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .